- ►diabetesjournals.org MC Beauchamp, G Renier - Diabetes, 2002 - Am Diabetes Assoc Hyperhomocysteinemia is an independent risk factor for cardiovascular disease in
human diabetes. Among the multiple factors that may account for the
atherogenicity of homocysteine (Hcys) in patients with diabetes, macrophage ... Cited by 27 - Related articles - BL Direct - All 4 versions
- ►jlr.org [PDF] G Renier, AC Desfaits, A Lambert, R Mikhail - The Journal of Lipid Research, 1996 - ASBMB Abstract We investigated, in the present study, the role of reactive oxygen
intermediates (ROI) in the control of macro- phage lipoprotein lipase (LPL)
secretion. Exposure of murine macrophages to increasing concentrations of ... Cited by 15 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org [PDF] MR Sartippour, A Lambert, M Laframboise, P … - Diabetes, 1998 - Am Diabetes Assoc Cardiovascular diseases are the leading cause of mor- bidity and mortality in
diabetes. Lipoprotein lipase (LPL), a major secretory product of macrophages,
has been suggested to play a key role in the development of ... Cited by 37 - Related articles - BL Direct - All 5 versions
- ►jlr.org MC Beauchamp, E Letendre, G Renier - The Journal of Lipid Research, 2002 - ASBMB FH is associated with accelerated atherosclerosis. Based on the crucial role of
macrophage LPL in atherogenesis, we determined in the present study macrophage
LPL expression in patients with FH. Monocytes isolated from 13 FH patients ... Cited by 19 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org SÉ Michaud, G Renier - Diabetes, 2001 - Am Diabetes Assoc Atherosclerosis is a major complication of type 2 diabetes. The pathogenesis of
this complication is poorly understood, but it clearly involves production in
the vascular wall of macrophage (Mo) lipoprotein lipase (LPL). Mo LPL is ... Cited by 55 - Related articles - BL Direct - All 5 versions
MR Sartippour, G Renier - Diabetes, 2000 - Am Diabetes Assoc Atherosclerosis is the major complication of diabetes. Accumulating evidence
indicates that lipoprotein lipase (LPL) produced by macrophages in the vascular
wall may favor the development of atherosclerosis by promoting lipid ... Cited by 40 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org JC Mamputu, L Levesque, G Renier - Arteriosclerosis, thrombosis, and vascular biology, 2000 - Am Heart Assoc Abstract—Vascular smooth muscle cell (VSMC) proliferation is a key event in
the development and progression of atherosclerotic lesions. Accumulating
evidence suggests that lipoprotein lipase (LPL) produced in the vascular ... Cited by 27 - Related articles - BL Direct - All 7 versions
- ►jlr.org [PDF] G Renier, E Skamene, JB DeSanctis, D … - The Journal of Lipid Research, 1994 - ASBMB Abstract In view of the suppressive effect of tumor necrosis factor a (TNFa) on
lipoprotein lipase (LPL) and of the potential proatherogenic effects of these
two macrophage secretory products, we have tested the possibility that LPL ... Cited by 36 - Related articles - BL Direct - All 3 versions
- ►jlr.org [PDF] JC Mamputu, AC Desfaits, G Renier - The Journal of Lipid Research, 1997 - ASBMB Abstract Lipoprotein lipase (LPL)-mediated lipolysis of very low density
lipoprotein (VLDL) has been demonstrated to in- crease U937 monocyte adhesion to
endothelial cells. In the present study, we evaluated the ability of LPL to ... Cited by 53 - Related articles - BL Direct - All 3 versions
- ►jlr.org [PDF] JR White, A Chait, SJ Klebanoff, S Deeb, JD … - The Journal of Lipid Research, 1988 - ASBMB Abrtract Human monocyte-derived macrophages secrete lipo- protein lipase (LPL)
in culture. The regulation of human mac- rophage LPL production is poorly
understood. Since bacterial lipopolysaccharide (LPS) alters production of ... Cited by 20 - Related articles - All 2 versions
